Drug shortages

Olipudase alfa-rpcp Injection

Sanofi-Aventis U.S. LLC · Available

Current58468-0050-1Endocrinology/Metabolism
Open FDA's page for this record
Update type
Revised
Initial posting date
11/16/2026
Package NDC
58468-0050-1
Generic name
Olipudase alfa-rpcp Injection
Contact info
888-847-4877
Availability
Available
Update date
11/19/2026
Dosage form
Injection
Presentation
Xenpozyme, Injection, 20 mg/5.1 mL (NDC 58468-0050-1)
Company name
Sanofi-Aventis U.S. LLC
Status
Current
Related info

Supply concerns for late November through early December 2026; See the following site for additional information from Sanofi: https://www.sanofi.com/en/our-science/therapeutic-areas/rare-diseases/supply-update

Therapeutic category
Endocrinology/Metabolism
Harmonized identifiers (openFDA)
Application number
BLA761261
Brand name
XENPOZYME
Generic name
OLIPUDASE ALFA-RPCP
Manufacturer name
Genzyme Corporation
Product NDC
58468-0050, 58468-0051
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS
Substance name
OLIPUDASE ALFA
RxCUI
2610411, 2610416, 2634357, 2634359
SPL ID
ce8d4153-ce95-43c4-9672-e1e951ebcdaa
SPL set ID
01a910ee-a33e-4be3-ac41-322d64c34311
Package NDC
58468-0050-1, 58468-0051-1
UNII
6D5766Q4OP
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.